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ABSTRACT	
Background:	Smartphone	technologies	and	mHealth	applications	(or	apps)	promise	unprecedented	
scope	for	data	collection,	treatment	intervention,	and	relapse	prevention	when	used	in	the	field	of	
substance	abuse	and	addiction.	This	potential	also	raises	new	ethical	challenges	that	researchers,	
clinicians,	and	software	developers	must	address.	Aims:	This	paper	aims	to	identify	ethical	issues	in	
the	current	uses	of	smartphones	in	addiction	research	and	treatment.	Methods:	A	search	of	three	
databases	(PubMed,	Web	of	Science	and	PsycInfo)	identified	33	studies	involving	smartphones	or	
mHealth	applications	for	use	in	the	research	and	treatment	of	substance	abuse	and	addiction.	A	
content	analysis	was	conducted	to	identify	how	smartphones	are	being	used	in	these	fields	and	to	
highlight	the	ethical	issues	raised	by	these	studies.	Results:	Smartphones	are	being	used	to	collect	
large	amounts	of	sensitive	information,	including	personal	information,	geo-location,	physiological	
activity,	self-reports	of	mood	and	cravings,	and	the	consumption	of	illicit	drugs,	alcohol	and	nicotine.	
Given	that	detailed	information	is	being	collected	about	potentially	illegal	behaviour,	we	identified	
the	following	ethical	considerations:	protecting	user	privacy,	maximising	equity	in	access,	ensuring	
informed	consent,	providing	participants	with	adequate	clinical	resources,	communicating	clinically	
relevant	results	to	individuals,	and	the	urgent	need	to	demonstrate	evidence	of	safety	and	efficacy	
of	the	technologies.	Conclusions:	mHealth	technology	offers	the	possibility	to	collect	large	amounts	
of	valuable	personal	information	that	may	enhance	research	and	treatment	of	substance	abuse	and	
addiction.	To	realise	this	potential	researchers,	clinicians	and	app-developers	must	address	these	
ethical	concerns	to	maximise	the	benefits	and	minimise	risks	of	harm	to	users.	
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INTRODUCTION	
Smartphones	are	a	powerful	and	ubiquitous	technology	that	combines	mobile	computing	with	
telecommunication	capabilities	(Mosa,	Yoo,	&	Sheets,	2012).	In	2011,	there	were	over	6	billion	
phone	subscriptions	reaching	87%	of	the	world’s	population	(ITU,	2011).	A	recent	survey	found	that	
43%	of	global	respondents	have	a	smartphone	(Poushter,	2016).	For	countries	such	as	Australia	or	
the	United	States,	this	figure	approaches	three-quarters	(Poushter,	2016).		There	is	growing	interest	
in	the	use	of	smartphones	and	other	mobile	technologies	for	conducting	research	on	drug	use	and	
addiction	and	intervening	to	reduce	drug	use	and	its	harmful	effects	(Kuntsche	&	Labhart,	2014;	
Meurk,	Hall,	Carter,	&	Chenery,	2014).		
The	ability	of	smartphones	to	run	third	party	software	applications	(or	apps)	has	generated	interest	
in	their	use	for	research	in	substance	abuse	and	addiction.	Smartphones	overcome	many	of	the	
traditional	limitations	of	addiction	research	that	rely	upon	pen	and	paper	surveys	or	diaries	and	
retrospective	recall.	Although	gathering	retrospective	self-report	may	be	cost-efficient	and	
convenient,	it	has	been	found	to	underestimate	substance	abuse	(Kuntsche	&	Labhart,	2014).	Self-
reported	drug	use	can	be	under-reported	if	participants	are	unwilling	to	reveal	the	true	amount	
consumed.	It	may	also	be	subject	to	recall	bias	when	users	only	remember	some	of	their	total	drug	
consumption	(Kuntsche	&	Labhart,	2014).	Surveys	of	drug	use	generally	underrepresent	heavy	
substance	abusers	in	the	population	(Kuntsche	&	Labhart,	2014).	Less	intrusive	smartphone	
technologies	can	encourage	a	wider	section	of	the	population	to	participate	in	surveys.	Less	time	is	
taken	to	fill	out	lengthy	questionnaires	and	diaries,	and	prompts	can	be	sent	throughout	the	day	to	
collect	a	greater	range	of	data	at	more	regular	intervals	(Kuntsche	&	Labhart,	2014).		
Smartphones	are	also	being	looked	at	for	use	in	healthcare	settings	to	improve	diagnosis	and	
personalise	treatment	(Mosa	et	al.,	2012).	Smartphones	may	enable	clinicians	and	other	health	care	
professionals	to	deliver	clinically	important	information	in	a	uniquely	timely	way.	For	example,	data	
collected	by	a	smartphone	could	trigger	clinically	relevant	messages	to	the	user	prior	to	any	drug	use	
(Luxton,	McCann,	Bush,	Mishkind,	&	Reger,	2011).	The	use	of	smartphone	technologies	for	this	
purpose	has	been	termed	mHealth	(Tamony,	Holt,	&	Barnard,	2015).		
mHealth	falls	within	the	broader	field	of	electronic	research	or	e-research	(Kypri	&	Lee,	2009;	Miller	
&	Sønderlund,	2010).	E-research	is	commonly	used	to	study	human	participants	from	populations	
difficult	to	identify,	recruit	and	retain	in	research	and	treatment.	Advantages	of	mHealth	and	e-
research	in	non-therapeutic	research	(e.g.	epidemiological,	social	and	behavioural,	humanities	
research)	(Barratt,	2012;	Meurk	et	al.,	2014;	Miller,	Johnston,	McElwee,	&	Noble,	2007;	Shearer	et	
al.,	2007),	include:	increased	participant	comfort	and	perceived	anonymity	that	encourages	more	
honest	disclosure;	improved	consent	processes	(Ford	Ii	et	al.,	2015;	Monney,	Penzenstadler,	Dupraz,	
Etter,	&	Khazaal,	2015;	R.	Patel	et	al.,	2015);	reduced	research	costs;	and	fewer	data	errors	(Miller	et	
al.,	2007;	Monney	et	al.,	2015).	These	approaches	have	also	proven	beneficial	with	human	
participants	in	therapeutic	research	domains	(i.e.	prevention,	treatment	and	other	interventions)	
include	greater	capacity	to	recruit	participants	for	clinical	studies,	more	efficient	intervention	
delivery,	improved	monitoring	of	adherence	to	treatment	protocols	(Vahabzadeh,	Lin,	Mezghanni,	
Epstein,	&	Preston,	2009),	and	capacity	to	produce	significant	intervention	effects	(Amstadter,	
Broman-Fulks,	Zinzow,	Ruggiero,	&	Cercone,	2009;	Neil,	Batterham,	Christensen,	Bennett,	&	Griffiths,	
2009).		
	 4	
For	both	research	and	treatment	of	addiction,	smartphone	monitoring	of	substance	use	or	
treatment	is	possible	through	passive	data	collection	or	via	direct	input	from	patients.	Smartphone	
apps	can	prompt	and	record	a	patient’s	self-reported	drug	consumption	and	cravings,	commonly	
referred	to	as	Ecological	Momentary	Assessment	(EMA)	(Serre,	Fatseas,	Swendsen,	&	Auriacombe,	
2015).	Smartphone	technologies	may	passively	record	patterns	of	movement	within	the	
environment,	for	example,	via	global	positioning	systems	(GPS),	wireless	local	area	networks	(or	Wi-
Fi),	Bluetooth,	accelerometers,	gyroscopes,	pressure-sensors,	proximity-sensing magnetometers,	
barometers,	humidity	sensors,	temperature	sensors,	and	ambient	light	sensors	(Luxton	et	al.,	2011).	
Microphones	and	cameras	are	able	to	record	images	and	sounds,	including	personal	conversations,	
in	the	vicinity	of	the	phone	(Pei	et	al.,	2013).	From	these	data	it	is	possible	to	deduce	rich	social	
information	about	an	individual,	including	their	identity,	gender,	age,	marital	status,	social	status,	
where	they	live,	where	their	children	go	to	school,	health,	sex	life,	religion,	mood,	and	whether	they	
visit	a	therapist,	and	if	so	how	often,	or	how	regularly	they	visit	drinking	or	gambling	establishments	
(A.	Carter,	Liddle,	Hall,	&	Chenery,	2015;	Gasson,	Warwick,	Kosta,	Royer,	&	Meints,	2011;	King,	2011;	
Pei	et	al.,	2013;	Shilton,	2009).		
Physiological	information	such	as	heart	rate,	blood	pressure	and	substance	concentration	levels	may	
be	measured	using	additional	sensors.	Remote	monitoring	devices,	for	example,	are	being	
developed	to	continuously	monitor	physiological	responses	or	precursors	to	cravings	or	relapse	in	
persons	being	treated	for	addiction	(Boyer,	Smelson,	Fletcher,	Ziedonis,	&	Picard,	2010;	Yu	et	al.,	
2012).	Smartphones	can	also	be	adapted	to	directly	monitor	physiological	responses	to	drug	
consumption,	such	as	sensor	bands	that	are	able	to	detect	electro-dermal	activity,	body	motion	and	
skin	temperature	(Boyer	et	al.,	2012).	This	information	may	be	linked	to	other	electronic	databases,	
either	commercially	available	or	through	agreement	with	other	government	agencies	(e.g.	personal	
medical	records).	Algorithms	may	then	be	developed	to	identify	behavioural	patterns	indicative	of	
treatment	progress,	such	as	treatment	response	and	triggers	for	cravings	and	behaviour	that	
increases	the	risk	of	relapse	(Ahsan	et	al.,	2013).	In	order	for	the	technology	to	provide	effective	
treatments,	robust	research	will	need	to	be	conducted.	Given	the	sensitive	information	being	
collected	and	intrusive	nature	of	the	equipment,	a	number	of	ethical	issues	arise.			
Ethical	issues	
mHealth	raises	novel	ethical	issues	for	research	because	it	differs	from	traditional	means	of	human	
participant	recruitment,	consent,	data	collection,	and	analysis	(A.	Carter	et	al.,	2015).	mHealth	
methods	alter	the	nature,	dynamics	and	potential	consequences	of	research	participation	and	are	
evolving	rapidly.	The	potential	negative	consequences	of	participation	in	mHealth	research	are	
particularly	salient	for	those	with	stigmatised	disorders	or	behaviour,	such	as	those	with	a	drug	
addiction	or	who	use	illicit	drugs	(Meurk	et	al.,	2014).		
There	are	also	concerns	surrounding	the	clinical	applications	of	mHealth	technology	for	addiction	or	
substance	abuse	treatment.	Confidentiality	and	informed	consent	procedures	may	need	to	be	
revised	to	consider	storage	locations	and	security.	Given	the	wide	market	available	and	possibility	
for	corporate	interest,	evidence	of	safe	and	effective	treatments	may	need	to	be	highlighted	prior	to	
distribution	among	potentially	vulnerable	users.		The	speed	of	growth	of	the	smartphone	app	
market	appears	to	have	outpaced	the	medical	fraternity’s	ability	to	address	these	ethical	challenges	
(Boyce,	2012).			
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The	pace	of	development	is	“forcing	researchers	and	research	regulators	to	rethink	and	re-evaluate	
such	fundamental	research	ethics	issues	as	privacy,	informed	consent,	ownership,	recruitment,	
public	versus	private	space,	research	and	scientific	integrity	itself”	(Buchanan	&	Hvizdak,	2009,	p.	37).	
The	World	Health	Organization	has	recognised	the	need	for	greater	consideration	of	the	ethical	use	
of	electronic	or	mobile	research	and	health.	Unfortunately,	progress	in	developing	ethical	guidance	
has	been	slow.	A	recent	NHMRC	Australian	Health	Ethics	Committee	(AHEC)	consultation	paper	on	
ethical	issues	in	alcohol	and	drug	research	acknowledged:	“The	National	Statement	was	published	
before	the	ethical	issues	raised	by	these	developments	became	apparent	so	it	currently	provides	no	
specific	guidance	for	Internet-based	or	other	forms	of	online	research”	(NHMRC,	2011,	p.	27).	This	is	
particularly	the	case	for	mobile	technologies.	Although	recent	guidelines	have	been	outlined	on	the	
use	of	digital	data	in	research	(Clark	et	al.,	2015),	ethical	guidelines	are	still	required	to	clarify	best	
practice	in	the	use	of	mHealth	technology	(A.	Carter	et	al.,	2015).		
It	is	important	that	ethical	regulation	of	the	research	and	clinical	use	of	smartphones	keeps	pace	
with	the	rapid	developments	in	these	technologies.	Traditional	ways	of	ensuring	the	confidentiality	
and	privacy	of	research	data	collected	on	drug	use	and	behaviour	are	not	sufficient	to	deal	with	the	
sophisticated	array	of	personal	data	that	are	collected	via	smartphone	technologies.	Research	teams	
and	clinicians	must	understand	these	ethical	implications	if	they	are	to	maximise	the	promise	of	this	
technology	and	minimise	any	unintended	harms.	These	ethical	concerns	depend	on	how	the	
technology	is	being	used,	and	the	sorts	of	safeguards	that	are	put	in	place.	The	use	of	appropriate	
technical	safeguards	during	the	development	of	apps	can	mitigate	many	of	these	concerns	(e.g.	by	
the	use	of	secure	in-boxes,	maximising	user	control	over	data	recorded,	transmission	of	data	using	
secure	methods,	and	providing	access	to	devices	for	those	that	do	not	have	them)	(A.	Carter	et	al.,	
2015).		The	current	lack	of	ethical	guidelines	in	this	area	can	“result	in	researchers	acting	with	less	
consideration,	and	even	behaving	unethically	towards	their	study	subjects”	(Bober,	2004,	p.	308).	
In	order	to	better	understand	the	ethical	issues	raised	by	the	use	of	smartphones	in	addiction	
research	and	treatment,	this	paper	aims	to	review	the	ways	in	which	smartphone	technologies	are	
currently	being	employed	in	the	field.	From	this	ethical	review,	we	will	conclude	with	a	set	of	
recommendations	for	the	development	and	use	of	mHealth	apps	for	researchers	and	clinicians	in	the	
field	of	substance	abuse	and	addiction.		
METHODS	
A	search	of	three	electronic	databases	(PubMed,	PsycInfo	and	Web	of	Science)	was	performed	by	HC	
using	the	following	terms:	(“substance	use”	OR	“substance	abuse”	OR	“drug	dependence”	OR	
addict*	OR	alcohol*	OR	smok*	OR	tobacco	OR	cannabis	OR	marijuana	OR	heroin	OR	cocaine	OR	
opioid	OR	opiate)	AND	(mHealth	OR	smartphone	OR	iPhone	OR	“mobile	phone	app”)	NOT	
(“smartphone	addiction”).Eighty-four	articles	were	downloaded	to	an	Endnote	database	for	further	
analysis	of	eligibility.	Titles	and	abstracts	of	the	articles	were	examined	to	identify	studies	fulfilling	
the	following	criteria:	1)	involving	mHealth	apps	or	smartphones	(defined	as	mobile	phones	with	on	
board	sensors,	internet	capability	and	the	ability	to	run	third	party	apps);	2)	for	use	in	the	research	
or	treatment	of	substance	abuse	or	addiction.	Articles	not	fulfilling	these	criteria	were	excluded	(n	=	
22).	Full-text	analysis	excluded	a	further	30	publications	because	they	either	did	not	fulfil	the	
inclusion	criteria,	provided	only	a	case	report	or	general	review	of	the	topic	or	re-published	data	
(Epstein	et	al.,	2009;	McTavish,	Chih,	Shah,	&	Gustafson,	2012).	Article	reference	lists	were	screened	
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identifying	one	additional	study	(Yu	et	al.,	2012).	The	final	analysis	comprised	of	33	unique	papers	
describing	35	mHealth/mobile	phone	applications	(see	Figure	1).	
[Figure	1	Trial	Flow	Diagram.]	
Data	Analysis	
The	data	was	transcribed	into	the	Statistical	Package	for	Social	Sciences	(SPSS)	Version	23.0	software	
to	be	analysed	quantitatively	and	also	tabulated	in	Microsoft	Word	for	qualitative	analysis.	Of	the	33	
studies	included	in	this	analysis,	10	used	smartphone	technology	to	collect	research	data	from	
participants	(Research	apps,	see	Table	S1)	and	23	focused	on	the	treatment	or	management	of	
addiction	and	substance	abuse	(Clinical	apps,	see	Table	S2).	A	content	analysis	identified	the	
following	relevant	themes:	substance	investigated,	study	aims	and	design,	information	recorded	as	
part	of	the	study,	how	information	was	stored	and	transferred	from	the	smartphone,	and	the	ethical	
considerations	highlighted	in	the	study.	We	then	examined	the	ethical	concerns	raised	by	these	
themes	and	assessed	the	measures	suggested	in	the	literature	to	mitigate	these	concerns.	We	then	
conducted	an	ethical	analysis	employing	a	pluralistic	principlist	approach	(Beauchamp	&	Childress,	
2009)	to	identify	additional	ethical	concerns	that	warrant	further	consideration	by	researchers,	
clinicians,	and	app	developers.		
RESULTS	
Substance	Investigated		
Approximately	half	of	the	apps	focused	on	tobacco	abuse	and	one-third	involved	alcohol	use	(see	
Table	1);	two	examined	heroin	addiction,	and	one	cocaine	abuse.	Three	studies	examined	addiction	
in	general,	either	covering	a	range	of	substances	or	not	specifying	the	substance	of	addiction.	
[Table	1	Substance	of	focus.]		
Study	Design	and	Aim	
The	majority	(37.1%)	of	studies	analysed	were	randomised	controlled	trials	(RCT)	of	clinical	
smartphone	apps.	Approximately	one-third	(31.4%)	were	observational	studies	of	intervention	
effects	on	participants’	behaviour;	seven	of	these	were	cohort	studies	and	four	were	case-control	
studies.	One-quarter	of	the	applications	reviewed	were	feasibility	studies.	Two	papers	were	reviews	
of	commercially	available	applications.	
Five	distinct	aims	of	the	apps	were	identified	(see	Table	2).	Over	half	aimed	to	induce	or	support	
behaviour	change,	such	as	smoking	cessation,	or	reduced	alcohol	consumption.	Other	applications	
aimed	at:	preventing	the	user	from	relapsing	to	drug	use;	assisting	the	user	to	monitor	their	
consumption;	and	encouraging	medication	adherence	in	the	treatment	of	alcohol	abuse.		
More	than	half	of	the	10	research	applications	used	text	messaging	and	EMA	protocols	to	assess	
relationships	between	cravings,	substance	use,	mood	or	proximity	to	retail	outlets	for	alcohol	or	
tobacco.	One	study	tested	the	reliability	and	validity	of	a	mobile	phone	based	breath	carbon-
monoxide	meter,	while	another	aimed	to	investigate	the	prevalence	of	smoking	in	vehicles.	Two	
studies	used	smartphone	apps	to	study	the	effects	of	alcohol	on	cognition:	one	used	games	to	
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measure	alcohol	intoxication	and	compared	this	with	blood	alcohol	concentration;	the	other	
examined	the	effectiveness	of	a	program	to	increase	executive	functioning	of	alcohol	abusers.		
[Table	2	Purpose	of	application.]	
Personal	Information	Recorded	
The	apps	collected	a	range	of	demographic	and	personal	information	(see	Table	3).	A	majority	
required	users	to	record	their	regular	consumption	habits,	daily	drug	use,	cravings,	or	triggers	of	
cravings.	Over	half	of	the	apps	obtained	personal	demographic	information	that	included	age,	
gender,	ethnicity,	education	level	and	employment.	Users’	locations	were	tracked	using	GPS	or	other	
geo-locating	sensors	by	more	than	one-fifth	of	the	applications	and	three	included	devices	that	
measured	physiological	data.	Three	obtained	this	information	via	user	self-report.	Six	apps	collected	
information	on	participants’	medical	history	or	their	use	of	prescribed	medications.	More	than	one-
third	of	apps	collected	information	on	users’	goals	for	recovery,	such	as	personal	motivations	or	
reasons	for	abstinence.		
[Table	3	Type	of	information	collected.]	
Data	Storage	and	Transfer	
One-quarter	of	the	studies	did	not	address	storage	security	or	methods	of	transferring	the	
information	from	the	device.	Almost	half	(48.6%)	utilised	‘secure’	online	storage	banks,	such	as	‘the	
cloud’,	and	wireless	or	3G	servers	to	transfer	this	information	(Ahsan	et	al.,	2013;	BinDhim,	
McGeechan,	&	Trevena,	2014;	Hertzberg	et	al.,	2013;	Reitzel	et	al.,	2014;	Renner,	2012;	Struik	&	
Baskerville,	2014).	The	remainder	either	stored	information	on	local	devices	(25.7%).	In	terms	of	
transfer	of	information,	over	half	of	the	studies	transferred	data	using	online	pathways	and	
approximately	one-fifth	(22.9%)	transferred	information	using	localised,	offline	devices.		
Ethical	Considerations	
After	reviewing	the	literature,	we	identified	the	following	ethical	issues	as	emerging	themes:	
protecting	the	privacy	of	the	information	collected	(assessed	by	attempts	to	ensure	user	anonymity,	
encryption	of	data,	consideration	of	storage	and	transfer	security,	password	protection,	private	
inboxes,	and	user	control);	ensuring	equal	access	to	the	technology	for	all	individuals;	and	providing	
appropriate	clinical	information	to	the	individual	(including	recommendations	for	supportive	
resources	for	substance	abuse	treatment)	(see	Table	4).		
Privacy	
Over	one	third	of	the	applications	reported	implementing	processes	that	aimed	to	preserve	user	
anonymity	(e.g.	unidentified	usernames,	de-identification	of	the	data).	Eleven	apps	used	data	
encryption	methods,	where	data	is	scrambled	to	make	it	indecipherable	by	third	parties	and	one-
fifth	used	password-protection.	Twenty	apps	provided	users	with	an	element	of	control	over	the	
utility	of	the	app.	For	example,	a	number	of	apps	sought	to	maintain	user	privacy	by	providing	the	
participant	with	the	ability	to	turn	off	alerts	at	certain	times	(Keoleian,	Stalcup,	Polcin,	Brown,	&	
Galloway,	2013;	Kirchner	et	al.,	2013;	McTavish	et	al.,	2012;	van	Mierlo	et	al.,	2014).	One	application	
allowed	the	user	to	switch	off	location	services	when	desired	(McTavish	et	al.,	2012),	potentially	
reducing	the	amount	of	unnecessary	data	collected	and	the	possibility	of	a	third-party	identifying	the	
user	through	data	profiling	(Gasson	et	al.,	2011).	
	 8	
Of	the	18	applications	that	used	text	messaging,	only	three	incorporated	a	separate	or	private	inbox	
for	the	user	(e.g.	(Hasin,	Aharonovich,	&	Greenstein,	2014;	Haug,	Kowatsch,	Castro,	Filler,	&	Schaub,	
2014)).	To	ensure	privacy	from	third	party	access,	if	the	device	is	lost	or	stolen,	a	small	number	of	
apps	used	password	protection	(e.g.	(Hertzberg	et	al.,	2013;	Renner,	2012;	van	Mierlo	et	al.,	2014)).		
Equal	access	to	the	technology	
Fourteen	of	the	studies	reviewed	took	steps	to	ensure	that	individuals	in	the	lower	socioeconomic	
population	had	access	to	mHealth	technology.	A	range	of	methods	were	observed,	such	as	providing	
the	participant	with	a	smartphone	device	(Dulin,	Gonzalez,	&	Campbell,	2014;	Ingersoll	et	al.,	2014;	
Johnson,	Barrault,	Nadeau,	&	Swendsen,	2009),	recruiting	participants	from	treatment	centres	
(Epstein	et	al.,	2009;	Johnson	et	al.,	2009;	Watkins	et	al.,	2014)	or	focusing	primarily	on	individuals	of	
lower	income	(Reitzel	et	al.,	2014;	Wen	et	al.,	2014).	Yet	more	than	half	of	the	studies	required	
participants	to	own	a	smartphone	device	or	have	access	to	the	Internet	(Keoleian	et	al.,	2013;	
Whittaker,	2011)	in	order	to	be	eligible	to	participate.	
Communication	of	clinical	information	
Over	half	of	the	studies	provided	external	support	resources	for	participants,	through	either	clinical	
treatment	as	part	of	the	study	(Boyer	et	al.,	2012;	Epstein	et	al.,	2009;	Ingersoll	et	al.,	2014;	
McTavish	et	al.,	2012),	personal	care	or	online	interactive	resources	(Dulin	et	al.,	2014;	McTavish	et	
al.,	2012).	However,	almost	half	of	the	studies	did	not	provide	any	resources	or	clinically	relevant	
information	for	users.	Finally,	six	apps	were	developed	alongside	not-for-profit,	independent	
organisations,	such	as	Quit	Victoria	(Ploderer,	Smith,	Pearce,	&	Borland,	2014)	or	the	Cancer	Council	
(Borland,	Balmford,	&	Benda,	2013;	Buller,	Borland,	Bettinghaus,	Shane,	&	Zimmerman,	2014).	
[Table	4	Ethical	issues	considered.]	
DISCUSSION	
A	range	of	research	methods	were	observed	in	the	33	unique	studies	of	smartphone	technologies	in	
addiction	research	and	treatment	and	it	was	encouraging	to	find	the	most	common	being	
randomised	controlled	trials,	the	‘gold	standard’	research	method.	Yet,	despite	some	in-depth,	
potentially	identifiable	information	being	collected	about	the	user,	many	studies	may	have	
overlooked	the	reliability	of	their	security	measures.	Such	oversight	has	implications	on	the	
participant’s	privacy	and	informed	consent.	Given	the	potential	vulnerability	of	the	population	in	
question,	ethical	issues	may	arise	when	using	mHealth	technology	for	treating	substance	abuse	
related	to	the	equal	availability	of	smartphone	technology	for	all,	communication	of	clinically	
relevant	information,	evidence	of	safety	and	effectiveness	of	the	app	as	well	as	the	process	of	app	
design.		
Privacy	
The	most	prominent	ethical	concern	with	mHealth	technology	is	protecting	the	privacy	of	users’	
personal	information.	The	mHealth	apps	we	reviewed	collected	a	range	of	sensitive	information,	
such	as	users’	demographic	characteristics,	drug	use,	mood	or	cravings.	From	such	data,	it	may	be	
possible	for	a	third	party	to	identify	persons	engaging	in	criminal	behaviours	(e.g.	consumption	or	
purchase	of	illicit	drugs),	the	locations	at	which	they	did	so,	and	the	details	of	others	who	may	also	
be	involved.	Given	the	sensitivity	of	the	information	collected,	researchers,	clinicians	and	app	
developers	have	an	ethical	obligation	to	take	steps	to	ensure	that	third	parties	cannot	access	such	
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information	and	to	be	aware	of	the	limitations	of	their	promises	to	protect	users’	privacy.	We	are	
unable	to	discern	from	this	study	whether	the	informed	consent	process	met	these	
recommendations.	The	inability	to	ensure	anonymity	and	guarantee	privacy	is	seldom	acknowledged	
in	the	mHealth	literature.	Although	a	breach	of	a	user’s	privacy	may	be	viewed	as	unlikely,	this	is	an	
area	that	requires	greater	attention.	
Data	storage	and	transfer	
Despite	collecting	information	about	potentially	illegal	behaviours,	many	studies	either	did	not	
address	storage	security,	or	utilised	online	storage	banks	where	the	level	of	security	is	unknown.	The	
risks	of	such	storage	locations	need	to	be	addressed.	Researchers	and	clinicians	cannot	guarantee	
that	information	stored	online	will	not	be	accessed	by	third	parties,	despite	password	protection,	as	
recent	high	profile	breaches	of	cloud	storage	illustrate	(Chu	et	al.,	2013;	"Cloud	hack	on	celebrities,"	
2014;	Timberg,	2014).	Furthermore,	entrusting	data	with	third-party	networks,	via	transmission	or	
storage,	can	increase	the	possibility	of	hacking.	There	is	also	a	question	about	data	ownership	by	
telecommunication	companies	and	cloud	storage	providers	through	which	the	data	is	transmitted	or	
stored	(e.g.	Internet	service	providers	(ISP),	Google,	Amazon)	(He,	Naveed,	Gunter,	&	Nahrstedt,	
2014).	
Third-party	access	
There	are	limits	to	the	extent	to	which	researchers,	clinicians	and	app-developers	can	guarantee	the	
privacy	of	participant	information,	despite	using	off-line,	secure	storage.	Drug	use	is	often	illicit	and	
may	be	of	interest	to	both	criminal	and	civil	courts	(e.g.	Family	Courts	in	custody	disputes).	If	
presented	with	a	subpoena,	researchers	and	clinicians	are	legally	required	to	hand	over	participant	
information	that	is	recorded	on	drug-related	apps.	Furthermore,	many	drug	users	are	engaged	in	
illegal	behaviour	(by	definition	in	using	an	illegal	drug),	and	frequently	come	under	the	surveillance	
of	the	authorities.	If	there	is	suspicion	that	they	have	engaged	in	illegal	activities,	law	enforcement	
officials	have	the	authority	to	demand	access	to	smartphone	data,	which	may	record	proof	of	illegal	
activity	of	study	participants	(e.g.	their	illicit	drug	use	or	property	crimes)	or	others	(e.g.	the	location	
of	their	drug	dealers).		
In	addition	to	carrying	larger	volumes	of	personal	data,	mobile	phones	are	often	permanent	
accompaniments	that	are	easily	visible	and	accessible	by	third	parties.	Despite	efforts	to	reduce	the	
risk	of	third	parties	accessing	the	app	or	user	information,	the	simple	presence	of	an	app	on	a	phone	
may	be	enough	to	disclose	that	the	person	has	an	addiction.	These	are	salient	issues	where	users	
may	be	subject	to	significant	stigmatisation	and	social	discrimination	(e.g.	by	employers,	educators,	
insurers).	Steps	should	be	taken	to	mitigate	unintended	discovery	of	the	app	or	the	data	recorded.	
These	limitations	should	also	be	acknowledged	through	transparent	and	robust	informed	consent	
procedures	(see	below).	
User	anonymity	
A	number	of	app	designers	have	taken	steps	to	ensure	that	the	data	they	collect	does	not	identify	
the	user.	For	example,	anonymous	usernames	were	employed	and	specific	details	were	removed	
from	the	data	that	could	uniquely	identify	a	person	(e.g.	personal	address)	(Ploderer	et	al.,	2014;	
Stoner	&	Hendershot,	2012;	van	Mierlo	et	al.,	2014).	Although	these	attempts	may	increase	user	
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anonymity,	they	can	be	ineffective	if	the	app	passively	collects	geo-location	data,	as	was	found	for	
two	apps	(BinDhim	et	al.,	2014;	Boyer	et	al.,	2012).	
Data	encryption	methods	were	utilised	by	some	apps,	where	data	is	scrambled	so	that	it	is	
indecipherable	by	third	parties.	Yet	the	security	of	this	procedure	is	uncertain	as	it	is	possible	for	
codes	to	be	broken	or	cracked	with	modern	computing	methods	(Wei,	Murugesan,	Kuo,	Naik,	&	
Krizanc,	2013).	Although	most	of	the	apps	that	used	encryption	methods	also	de-identified	the	data	
collected	(Ahsan	et	al.,	2013;	BinDhim	et	al.,	2014;	Boyer	et	al.,	2012;	Gajecki,	Berman,	Sinadinovic,	
Rosendahl,	&	Andersson,	2014;	Gamito	et	al.,	2014;	Renner,	2012;	Stoner	&	Hendershot,	2012;	van	
Mierlo	et	al.,	2014),	collecting	a	wide	range	of	data,	including	geo-location,	renders	it	possible	to	
construct	a	data	profile	that	may	identify	the	user	(Gasson	et	al.,	2011).	
Some	features	included	in	a	number	of	apps	may	threaten	users’	privacy.	For	example,	alerts	
employed	by	smartphones	to	collect	research	data	may	attract	the	attention	of	third	parties	(B.	L.	
Carter	et	al.,	2008;	Dulin	et	al.,	2014;	Johnson	et	al.,	2009).	Such	approaches	may	increase	the	
privacy	and	control	a	participant	has	over	their	data	and	the	intrusiveness	of	the	app,	but	at	the	cost	
of	reducing	its	research	value	if	data	are	missed.	This	trade	off	must	be	carefully	balanced	during	
research	design	and	ethical	review.	
Informed	Consent	
It	is	imperative	that	participants	in	smartphone	research	or	users	of	mHealth	apps	for	treatment	of	
addiction	are	fully	informed	of	the	potential	risks	to	their	privacy	and	the	limitations	on	researchers	
and	clinicians’	ability	to	protect	this	privacy.	Presently,	the	technological	and	legal	implications	of	
these	devices	may	be	difficult	for	both	participants	and	researchers	to	comprehend.	For	example,	
researchers	who	used	an	mHealth	app	for	individuals	recovering	from	alcohol	dependence	
conducted	focus	groups	to	examine	users’	perceptions	of	GPS	tracking	(D.	Gustafson	et	al.,	2011).	
Most	users	were	quite	open	to	location	tracking,	provided	the	data	were	only	shared	with	their	
permission.	Despite	the	limited	ability	to	protect	privacy	of	information	on	illicit	substance	use,	the	
researchers	did	not	clarify	the	limits	to	privacy	or	describe	the	amount	of	information	that	may	be	
gleaned	from	the	devices.		
Some	long-term	dependent	drug	users	may	have	cognitive	or	learning	impairments	that	interfere	
with	their	ability	to	understand	the	ethical	implications	raised	by	the	technologically	sophisticated	
use	of	smartphone	apps.	Researchers	and	clinicians	must	take	this	into	consideration	by	designing	
informed	consent	procedures	that	explain	this	technologically	complex	information	in	ways	that	
facilitate	comprehension	(e.g.	by	using	visual	aids	and	testing	comprehension).	Furthermore,	as	the	
legal	situation	is	different	in	different	countries,	researchers	and	clinicians	should	be	aware	of	the	
laws	affecting	their	area.	
Equal	Access	to	mHealth	Technology	
The	expense	of	buying	smartphones	and	telephone	plans	may	prevent	vulnerable	populations	from	
accessing	mHealth	services	or	participating	in	research.	This	can	amplify	inequities	in	access	to	
healthcare.	While	there	has	been	a	rapid	growth	in	mobile	phone	coverage	in	recent	years,	some	
segments	of	the	population	still	lack	access	(Labrique,	Kirk,	Westergaard,	&	Merritt,	2013).	A	recent	
study	on	mobile	phone	use	in	substance	abuse	patients	found	that	although	the	majority	owned	a	
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mobile	phone,	only	half	had	smartphone	capabilities	and	three-quarters	were	on	pay-as-you-go	
contracts	(Milward,	Day,	Wadsworth,	Strang,	&	Lynskey,	2015).	mHealth	applications	that	require	
internet	access	and	costly	data	transmission	may	be	unaffordable	and	thus	inaccessible	for	
significant	portions	of	the	drug	dependent	population.		
More	than	half	of	the	studies	reviewed	required	participants	to	own	a	smartphone	device	or	have	
access	to	the	Internet	in	order	to	be	eligible	to	participate.	These	requirements	exclude	individuals	
who	may	not	have	access	to	smartphone	technology.	Given	that	drug	users	tend	to	be	over-
represented	in	lower	socioeconomic	populations,	there	is	an	ethical	imperative	to	ensure	that	these	
patients	are	not	prevented	from	benefitting	from	mHealth	monitoring	(Labrique	et	al.,	2013).	
Furthermore,	study	results	will	be	skewed	if	such	a	population	is	ignored	and	as	a	result	those	in	
most	need	of	rehabilitation	or	support	are	excluded	from	participating	in	important	research	or	from	
receiving	treatment	benefits.	
Communication	of	Clinical	Information	to	Participants	
A	critical	decision	in	using	smartphones	for	clinical	purposes	is	how	to	communicate	results	to	users.	
The	provision	of	immediate	and	ubiquitous	feedback	of	information	has	the	potential	to	empower	
and	assist	patients	to	better	manage	their	health	and	to	improve	clinician/patient	relationships	
(Boyce,	2012).	This	issue	was	only	considered	by	a	small	number	of	studies.	One,	for	example,	
provided	detailed	personalised	feedback	in	the	form	of	graphs	and	summaries	and,	after	30	days,	
patients	met	with	counsellors	to	ensure	that	they	understood	the	feedback	(Hasin	et	al.,	2014).	
Other	apps	fulfilled	this	ethical	requirement	by	providing	users	with	features	mapping	their	self-
reported	progress	in	the	form	of	monetary	or	health	benefits	trackers	(BinDhim	et	al.,	2014;	Bricker	
et	al.,	2014;	Struik	&	Baskerville,	2014).	To	be	clinically	meaningful,	however,	the	findings	must	be	
scientifically	robust	and	presented	in	a	way	that	the	patient	understands.		
At	a	minimum,	apps	must	provide	information	on	clinical	services	and	resources	available	to	the	
person	both	via	and	external	to	the	app.	It	is	not	only	important	that	app	developers	and	researchers	
facilitate	access	to	clinical	information	and	services,	but	also	that	they	are	factual	and	maximise	
benefits	to	the	user.		
Evidence	of	Safety	and	Effectiveness	
In	order	to	minimise	any	risk	of	harms	to	the	users,	app-developers	should	provide	evidence	of	the	
safety	and	effectiveness	of	the	apps	before	making	them	available	to	the	public.	This	urgent	need	
was	recognized	by	the	World	Health	Organization	and	other	leading	health	agencies	in	the	Bellagio	
call	to	action	on	global	eHealth	evaluation	that	called	for	rigorous	evaluation	“to	generate	evidence	
and	promote	the	appropriate	integration	and	use	of	technologies...to	improve	health	and	reduce	
health	inequalities”	(The	Bellagio	eHealth	Evaluation	Group,	2011,	p.	1).	One	app,	for	example,	
included	alerts	to	warn	users	when	they	were	entering	a	location	where	they	may	be	at	risk	of	a	
relapse	to	drinking	(Dulin	et	al.,	2014).	Without	evidence	of	safety	and	effectiveness,	alerts	such	as	
this	may	unintentionally	remind	the	user	of	an	opportunity	to	use	their	drug	and	induce	craving.		
Although	some	apps	were	developed	alongside	independent	organisations,	many	that	are	publicly	
available	are	created	by	commercial	developers	who	are	not	subject	to	the	same	ethical	guidelines	
as	university	or	hospital-based	researchers	(Abroms,	Westmaas,	Bontemps-Jones,	Ramani,	&	
	 12	
Mellerson,	2013).	Given	the	simplicity	and	cost-effectiveness	of	mHealth	solutions,	decision-makers	
may	overlook	the	lack	of	robust	empirical	evidence	in	deciding	whether	to	use	them	(Boyce,	2012).	
The	implementation	of	untested	mHealth	interventions	may	result	in	failed	projects,	wasted	
resources,	and	poorer	health	outcomes	for	those	using	these	services.	In	order	to	benefit	the	user,	it	
is	imperative	that	the	mHealth	apps	used	by	researchers,	clinicians,	universities	and	hospitals	are	
supported	by	rigorous	evidence	of	safety	and	efficacy	(Boyce,	2012).	
App	Design	and	Development	
The	development	and	investigation	of	these	apps	requires	engagement	with	users	and	other	
stakeholders	to	identify	their	concerns	and	develop	processes	that	protect	the	participant	and	
maximise	the	utility	and	effectiveness	of	the	intervention.	Focus	groups	were	employed	throughout	
the	development	process	for	a	number	of	papers	developing	apps	for	smoking	cessation	(Giroux,	
Bacon,	King,	Dulin,	&	Gonzalez,	2014;	Ybarra,	Holtrop,	Prescott,	&	Strong,	2014).	Although	important	
for	enhancing	user	access	and	utility,	issues	related	to	participant	privacy	were	not	addressed.	
Researchers	and	app	developers	need	to	consider	ethical	issues	when	designing	mHealth	technology	
for	addiction	research	and	treatment	purposes.	A	consideration	of	these	issues	should	not	be	left	
until	after	an	app	has	been	designed.	This	will	not	optimally	meet	the	ethical	challenges,	mitigate	
any	risk	of	harm	for	users,	or	maximise	participant	autonomy.	We	propose	a	number	of	
recommendations	for	the	development	and	use	of	such	technology	for	substance	abuse	and	
addiction	(see	Box.	1).	
Limitations	and	Future	Directions	
The	present	paper	has	reviewed	the	literature	on	the	use	of	mHealth	technology	for	research	and	
treatment	of	substance	abuse	or	addiction.	We	have	identified	a	number	of	ethical	concerns	and	
have	provided	recommendations	for	researchers,	clinicians	and	app	developers	that	would	
contribute	to	ensuring	user	privacy	is	maintained	and	standard	ethical	principles	are	not	violated	
with	the	fast-developing	technology.	Due	to	the	nature	of	the	research,	however,	some	limitations	
are	acknowledged.	The	present	review	was	limited	to	the	use	of	smartphones	published	in	academic	
journals	only.	This	may	have	excluded		commercially	available	apps	that	were	not	being	tested	by	
researchers.	A	review	of	apps	available	on	commercial	platforms	is	recommended	for	future	
research.	The	use	of	smartphones	in	addiction	research	and	treatment	involves	complex,	technically	
specific	research	and	knowledge.	We	believe	that	multidisciplinary	working	groups	are	needed	to	
examine	the	complex	technical	issues	involved	in	ensuring	the	ethical	use	of	smartphone	apps	in	
research	and	treatment,	and	to	develop	a	set	of	easily	understood	guidelines	for	both	researchers	
and	clinicians	about	the	minimum	standard	ethical	requirements	for	the	design	and	use	of	this	
promising	technology.	
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Ethical	Consideration	 Recommendations	
Data	storage	and	
transfer	
Serious	consideration	should	be	given	to	where	the	data	is	stored	and	how	it	is	
transmitted	from	the	device.	Online	transmission	and	storage	should	be	
avoided	in	favour	of	localised	storage	units	that	can	only	be	accessed	by	
authorised	personnel.	Only	data	relevant	to	the	aims	of	the	study	or	purpose	
of	the	application	should	be	collected.		
Data	ownership	 If	data	is	to	be	stored	on	third	party	networks,	clear	guidelines	should	be	
provided	prior	to	data	collection	that	outlines	to	all	parties	who	has	rights	to	
access	the	data	and	which	parties	own	the	data.	
Third-party	access	 Password	protection	or	private	inbox	features	should	be	utilised	to	prevent	
accidental	third	party	access	to	the	app/device.	Individuals	should	be	informed	
of	the	potential	for	third	parties	to	access	their	data,	through	legal	means,	or	
hacking.		
User	anonymity	 Data	encryption	methods	can	reduce	likelihood	of	third-party	access	to	
information	but	their	limitations	must	be	relayed	to	the	user.	Users	need	to	be	
made	aware	if	de-identification	processes	are	not	possible.	Where	possible,	
users	should	be	given	power	to	control	how	much	information	is	collected	and	
when.	
Informed	consent		 mHealth	users	need	to	be	informed	of	the	risks	and	benefits	of	the	technology	
in	a	way	that	is	clear	and	understandable.	This	includes	limits	to	confidentiality	
and	privacy,	for	example,	court	orders	or	subpoena.		
Access	to	mHealth	
technologies		
Strategies	need	to	be	used	to	ensure	that	individuals	from	minority	groups,	
such	as	lower	socioeconomic	populations	or	those	with	a	disability,	have	equal	
access	to	the	benefits	of	mHealth	technology.	Provision	of	devices	to	research	
participants	will	include	those	most	in	need	and	ensure	a	more	representative	
sample.			
Communication	of	
clinically	relevant	
results	
Feedback	of	clinically	relevant	information	should	be	relayed	to	the	user	in	a	
manner	that	they	understand	but	only	when	there	is	strong	empirical	evidence	
to	support	the	findings.	Users	should	also	be	provided	with	access	to	external	
resources	for	evidence-based,	clinical	support	for	their	addiction.	
Evidence	of	safety	and	
effectiveness	
Interventions	encompassed	in	mHealth	technology	should	only	be	utilised	if	
prospectively	shown	to	be	safe,	effective	and	of	benefit	to	the	consumer.	
Regulation	of	mHealth	
products	
A	regulatory	process	is	needed	to	carefully	evaluate	mHealth	apps	and	require	
evidence	of	safety,	effectiveness,	and	ethical	conduct	before	routine	public	
distribution	and	clinical	use.	
Box	1	Recommendations	for	researchers,	clinicians,	and	app	developers	when	using	and	designing	
mHealth	technology	for	therapeutic	and	non-therapeutic	addiction	research.	
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CONCLUSIONS	
Smartphone	and	mHealth	technology	provide	unique	possibilities	for	collecting	valuable	information	
about	research	and	for	the	treatment	of	substance	abuse	and	addiction.	Given	the	wide	scope	of	
personal	information	that	can	be	collected,	the	promise	of	these	technologies	also	raise	a	number	of	
ethical	issues.	Our	analysis	suggests	that	there	is	a	lack	of	awareness	of	the	ethical	issues	raised	by	
their	use,	the	implications	for	how	the	apps	are	developed,	and	how	both	research	and	clinical	
treatments	are	conducted.	Given	the	sensitivity	of	information	being	collected	(e.g.	illegal	
behaviours),	it	is	an	ethical	imperative	for	researchers,	app-developers	and	clinicians	to	protect	the	
rights	and	privacy	of	the	users.	There	is	currently	a	lack	of	attention	to	where	information	is	being	
stored,	the	level	of	security	involved,	and	how	it	is	being	transferred	(He	et	al.,	2014;	Su,	2014).	App-
developers	and	researchers	need	to	ensure	that	apps	are	designed	in	a	way	that	reduce	the	risk	of	
personal	information	being	accessed	by	third	parties	and	maximises	user	anonymity.	There	is	great	
potential	of	mHealth	technology,	yet	it	is	imperative	that	we	first	address	these	ethical	
considerations	to	ensure	that	we	capitalise	on	the	possible	benefits	of	these	technologies	while	
minimising	the	potential	risks	to	the	users.	
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Tables	and	Figures	
	
	
Figure	1	Flow	diagram	for	literature	search	and	study	inclusion.	
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Table	1	Substance	focus.	
Substance	 N	(%)	 References	
Tobacco	 17	(48.6%)	 (Ahsan	et	al.,	2013;	BinDhim	et	al.,	2014;	Borland	
et	al.,	2013;	Bricker	et	al.,	2014;	Buller	et	al.,	2014;	
B.	L.	Carter	et	al.,	2008;	Haug	et	al.,	2014;	
Hertzberg	et	al.,	2013;	Kirchner	et	al.,	2013;	
Meredith	et	al.,	2014;	V.	Patel,	Nowostawski,	
Thomson,	Wilson,	&	Medlin,	2013;	Ploderer	et	al.,	
2014;	Reitzel	et	al.,	2014;	Struik	&	Baskerville,	
2014;	van	Mierlo	et	al.,	2014;	Watkins	et	al.,	2014;	
Whittaker,	2011)	
Alcohol	 12	(34.3%)	 (Bendtsen	&	Bendtsen,	2014;	Dulin	et	al.,	2014;	
Gajecki	et	al.,	2014;	Gamito	et	al.,	2014;	Hasin	et	
al.,	2014;	Haug	et	al.,	2014;	Kauer,	Reid,	Sanci,	&	
Patton,	2009;	Matsumura,	Yamakoshi,	&	Ida,	
2009;	McTavish	et	al.,	2012;	Renner,	2012;	Stoner	
&	Hendershot,	2012;	Yu	et	al.,	2012)	
Heroin	 2	(5.7%)	 (Boyer	et	al.,	2012;	Epstein	et	al.,	2009)	
Cocaine	 1	(2.9%)	 (Freedman,	Lester,	McNamara,	Milby,	&	
Schumacher,	2006)	
General	 3	(8.6%)	 (Campling,	2011;	Ingersoll	et	al.,	2014;	Johnson	et	
al.,	2009)	
	
Table	2	Purpose	of	mHealth	applications.	
Purpose	 N	(%)	 References	
Behaviour	change	 18	(51.4%)	 (Ahsan	et	al.,	2013;	Bendtsen	&	Bendtsen,	2014;	
BinDhim	et	al.,	2014;	Borland	et	al.,	2013;	Bricker	
et	al.,	2014;	Buller	et	al.,	2014;	Dulin	et	al.,	2014;	
Hasin	et	al.,	2014;	Haug	et	al.,	2014;	Hertzberg	et	
al.,	2013;	Ingersoll	et	al.,	2014;	Ploderer	et	al.,	
2014;	Renner,	2012;	Struik	&	Baskerville,	2014;	
van	Mierlo	et	al.,	2014;	Whittaker,	2011;	Yu	et	al.,	
2012)	
Relapse	prevention	 3	(8.6%)	 (Boyer	et	al.,	2012;	Campling,	2011;	McTavish	et	
al.,	2012)	
Medication	adherence	 1	(2.9%)	 (Stoner	&	Hendershot,	2012)	
Monitor	consumption	 5	(14.3%)	 (Gajecki	et	al.,	2014;	Gamito	et	al.,	2014;	Kauer	et	
al.,	2009;	Matsumura	et	al.,	2009;	V.	Patel	et	al.,	
2013)	
Research	only	 8	(22.9%)	 (B.	L.	Carter	et	al.,	2008;	Epstein	et	al.,	2009;	
Freedman	et	al.,	2006;	Johnson	et	al.,	2009;	
Kirchner	et	al.,	2013;	Meredith	et	al.,	2014;	
Reitzel	et	al.,	2014;	Watkins	et	al.,	2014)	
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Table	3	Type	of	information	collected.	
Type	of	Information	
Collected	
N	(%)	 References	
Demographics	 20	(57.1%)	 (Ahsan	et	al.,	2013;	BinDhim	et	al.,	2014;	Borland	et	al.,	2013;	
Bricker	et	al.,	2014;	Buller	et	al.,	2014;	B.	L.	Carter	et	al.,	2008;	
Epstein	et	al.,	2009;	Gajecki	et	al.,	2014;	Gamito	et	al.,	2014;	
Haug	et	al.,	2014;	Hertzberg	et	al.,	2013;	Johnson	et	al.,	2009;	
Kauer	et	al.,	2009;	Kirchner	et	al.,	2013;	Matsumura	et	al.,	2009;	
McTavish	et	al.,	2012;	Reitzel	et	al.,	2014;	Struik	&	Baskerville,	
2014;	van	Mierlo	et	al.,	2014;	Watkins	et	al.,	2014)	
Location	 	 	
Self-Reported	 3	(8.6%)	 (Epstein	et	al.,	2009;	Freedman	et	al.,	2006;	V.	Patel	et	al.,	2013)	
GPS	tracking	 8	(22.9%)	 (BinDhim	et	al.,	2014;	Boyer	et	al.,	2012;	Dulin,	Gonzalez,	King,	
Giroux,	&	Bacon,	2013;	Kirchner	et	al.,	2013;	McTavish	et	al.,	
2012;	Reitzel	et	al.,	2014;	Struik	&	Baskerville,	2014;	Watkins	et	
al.,	2014)	
Consumption	habits	 26	(74.3%)	 (Ahsan	et	al.,	2013;	Bendtsen	&	Bendtsen,	2014;	BinDhim	et	al.,	
2014;	Borland	et	al.,	2013;	Bricker	et	al.,	2014;	Buller	et	al.,	2014;	
Campling,	2011;	B.	L.	Carter	et	al.,	2008;	Dulin	et	al.,	2014;	
Epstein	et	al.,	2009;	Freedman	et	al.,	2006;	Gajecki	et	al.,	2014;	
Haug	et	al.,	2014;	Hertzberg	et	al.,	2013;	Johnson	et	al.,	2009;	
Kauer	et	al.,	2009;	McTavish	et	al.,	2012;	Reitzel	et	al.,	2014;	
Renner,	2012;	Struik	&	Baskerville,	2014;	van	Mierlo	et	al.,	2014;	
Watkins	et	al.,	2014;	Whittaker,	2011;	Yu	et	al.,	2012)	
Cravings/Triggers		 24	(68.6%)	 (Ahsan	et	al.,	2013;	BinDhim	et	al.,	2014;	Borland	et	al.,	2013;	
Boyer	et	al.,	2012;	Bricker	et	al.,	2014;	Buller	et	al.,	2014;	B.	L.	
Carter	et	al.,	2008;	Dulin	et	al.,	2014;	Epstein	et	al.,	2009;	
Freedman	et	al.,	2006;	Hasin	et	al.,	2014;	Haug	et	al.,	2014;	
Ingersoll	et	al.,	2014;	Johnson	et	al.,	2009;	McTavish	et	al.,	
2012;	Reitzel	et	al.,	2014;	Renner,	2012;	Stoner	&	Hendershot,	
2012;	Struik	&	Baskerville,	2014;	van	Mierlo	et	al.,	2014;	
Watkins	et	al.,	2014;	Whittaker,	2011;	Yu	et	al.,	2012)	
Physiological	response	 3	(8.6%)	 (Boyer	et	al.,	2012;	Meredith	et	al.,	2014;	Yu	et	al.,	2012)	
Medical	history	 6	(17.1%)	 (Borland	et	al.,	2013;	Bricker	et	al.,	2014;	Buller	et	al.,	2014;	
Gamito	et	al.,	2014;	Johnson	et	al.,	2009;	van	Mierlo	et	al.,	
2014)	
Daily	drug	use	 30	(85.7%)	 (Ahsan	et	al.,	2013;	Bendtsen	&	Bendtsen,	2014;	BinDhim	et	al.,	
2014;	Borland	et	al.,	2013;	Bricker	et	al.,	2014;	Buller	et	al.,	
2014;	Campling,	2011;	A.	Carter,	Liddle,	J.,	Hall,	W.,	Chenery,	H.,	
2015;	Dulin	et	al.,	2014;	Epstein	et	al.,	2009;	Freedman	et	al.,	
2006;	Gajecki	et	al.,	2014;	Hasin	et	al.,	2014;	Haug	et	al.,	2014;	
Hertzberg	et	al.,	2013;	Ingersoll	et	al.,	2014;	Johnson	et	al.,	
2009;	Kauer	et	al.,	2009;	Matsumura	et	al.,	2009;	McTavish	et	
al.,	2012;	Meredith	et	al.,	2014;	Ploderer	et	al.,	2014;	Reitzel	et	
al.,	2014;	Renner,	2012;	Stoner	&	Hendershot,	2012;	Struik	&	
Baskerville,	2014;	van	Mierlo	et	al.,	2014;	Watkins	et	al.,	2014;	
Whittaker,	2011)	
Goals	for	recovery	 13	(37.1%)	 (Ahsan	et	al.,	2013;	BinDhim	et	al.,	2014;	Borland	et	al.,	2013;	
Bricker	et	al.,	2014;	Buller	et	al.,	2014;	Campling,	2011;	Hasin	et	
al.,	2014;	Haug	et	al.,	2014;	McTavish	et	al.,	2012;	Stoner	&	
	 18	
Hendershot,	2012;	Struik	&	Baskerville,	2014;	van	Mierlo	et	al.,	
2014)	
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Table	4	Ethical	issues	considered.	
Ethical	consideration	 N	(%)	 References	
Privacy	 	 	
User	anonymity	 13	(38.2%a)	 (Ahsan	et	al.,	2013;	BinDhim	et	al.,	2014;	Borland	et	al.,	
2013;	Freedman	et	al.,	2006;	Gajecki	et	al.,	2014;	Gamito	et	
al.,	2014;	Haug	et	al.,	2014;	Matsumura	et	al.,	2009;	V.	
Patel	et	al.,	2013;	Renner,	2012;	Stoner	&	Hendershot,	
2012;	van	Mierlo	et	al.,	2014)	
Data	encryption	 11	(32.3%b)	 (Ahsan	et	al.,	2013;	BinDhim	et	al.,	2014;	Boyer	et	al.,	2012;	
Gajecki	et	al.,	2014;	Gamito	et	al.,	2014;	Haug	et	al.,	2014;	
Meredith	et	al.,	2014;	Renner,	2012;	Stoner	&	Hendershot,	
2012;	Struik	&	Baskerville,	2014;	van	Mierlo	et	al.,	2014)	
Password	protection	 7	(24.1%c)	 (Boyer	et	al.,	2012;	Hasin	et	al.,	2014;	Haug	et	al.,	2014;	
Hertzberg	et	al.,	2013;	V.	Patel	et	al.,	2013;	Renner,	2012;	
van	Mierlo	et	al.,	2014)	
User	control	 20	(69.0%d)	 (Bendtsen	&	Bendtsen,	2014;	BinDhim	et	al.,	2014;	Bricker	
et	al.,	2014;	Campling,	2011;	B.	L.	Carter	et	al.,	2008;	
Gajecki	et	al.,	2014;	Haug	et	al.,	2014;	Hertzberg	et	al.,	
2013;	Ingersoll	et	al.,	2014;	Kauer	et	al.,	2009;	McTavish	et	
al.,	2012;	Ploderer	et	al.,	2014;	Reitzel	et	al.,	2014;	Renner,	
2012;	Struik	&	Baskerville,	2014;	van	Mierlo	et	al.,	2014;	
Watkins	et	al.,	2014;	Whittaker,	2011;	Yu	et	al.,	2012)	
Private	inbox	 3	(16.7%e)	 (Buller	et	al.,	2014;	Hasin	et	al.,	2014;	Haug	et	al.,	2014)	
Equity	in	access	 14	(46.7%f)	 (Boyer	et	al.,	2012;	A.	Carter,	Liddle,	J.,	Hall,	W.,	Chenery,	
H.,	2015;	Dulin	et	al.,	2014;	Epstein	et	al.,	2009;	Freedman	
et	al.,	2006;	Gamito	et	al.,	2014;	Hasin	et	al.,	2014;	
Ingersoll	et	al.,	2014;	Johnson	et	al.,	2009;	Kauer	et	al.,	
2009;	McTavish	et	al.,	2012;	Reitzel	et	al.,	2014;	Watkins	et	
al.,	2014;	Yu	et	al.,	2012)	
Support	resources	 19	(55.9%g)	 (Bendtsen	&	Bendtsen,	2014;	Bricker	et	al.,	2014;	Buller	et	
al.,	2014;	Dulin	et	al.,	2014;	Epstein	et	al.,	2009;	Freedman	
et	al.,	2006;	Gajecki	et	al.,	2014;	Hasin	et	al.,	2014;	Haug	et	
al.,	2014;	Hertzberg	et	al.,	2013;	McTavish	et	al.,	2012;	
Ploderer	et	al.,	2014;	Reitzel	et	al.,	2014;	Struik	&	
Baskerville,	2014;	van	Mierlo	et	al.,	2014;	Watkins	et	al.,	
2014;	Yu	et	al.,	2012)	
aOne	application	was	coded	as	not	applicable	(NA)	for	this	ethical	consideration	as	personal	information	was	not	collected	
(Meredith	et	al.,	2014).	bOne	application	was	coded	as	NA	for	this	ethical	consideration	as	it	was	not	invasive	to	the	users	
privacy	(V.	Patel	et	al.,	2013).	cSix	applications	were	coded	as	NA	for	this	ethical	consideration	as	the	apps	were	used	in	
controlled	experimental	conditions	(Freedman	et	al.,	2006;	Gamito	et	al.,	2014;	Matsumura	et	al.,	2009;	Meredith	et	al.,	
2014;	Reitzel	et	al.,	2014;	Watkins	et	al.,	2014).	dSix	applications	were	coded	as	NA	for	this	ethical	consideration	as	they	
were	either	used	in	controlled	experimental	conditions	or	were	not	invasive	to	the	users	privacy	(Epstein	et	al.,	2009;	
Freedman	et	al.,	2006;	Gamito	et	al.,	2014;	Matsumura	et	al.,	2009;	Meredith	et	al.,	2014;	V.	Patel	et	al.,	2013).	e17	
applications	were	coded	as	NA	for	this	ethical	consideration	as	messaging	was	not	included	in	the	features	(Ahsan	et	al.,	
2013;	BinDhim	et	al.,	2014;	Bricker	et	al.,	2014;	Epstein	et	al.,	2009;	Freedman	et	al.,	2006;	Gamito	et	al.,	2014;	D.	H.	
Gustafson	et	al.,	2014;	Hasin	et	al.,	2014;	Hertzberg	et	al.,	2013;	Matsumura	et	al.,	2009;	Meredith	et	al.,	2014;	V.	Patel	et	
al.,	2013;	Ploderer	et	al.,	2014;	Reitzel	et	al.,	2014;	Stoner	&	Hendershot,	2012;	Struik	&	Baskerville,	2014;	Watkins	et	al.,	
2014).	fFive	applications	were	coded	as	NA	for	this	ethical	consideration	as	they	were	part	of	exploratory/feasibility	studies	
(Ahsan	et	al.,	2013;	Matsumura	et	al.,	2009;	Meredith	et	al.,	2014;	V.	Patel	et	al.,	2013;	Struik	&	Baskerville,	2014).	gOne	
application	was	coded	as	NA	for	this	ethical	consideration	as	the	users	of	the	app	were	not	being	studied	for	their	personal	
substance	abuse	(V.	Patel	et	al.,	2013).	
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